HIV in 2023: Risks and Opportunities

40 years since the advent of the HIV pandemic there is much to celebrate including the advent of long-acting injectable therapy that liberates people from the burden of daily oral therapy. However, the recent mpox pandemic reminds us that despite the therapeutic advances, HIV-related immunosuppression remains a life-threatening illness.

This seminar will be presented Chloe Orkin, a Professor of Infections and Inequities, Director of the SHARE collaborative at Queen Mary University of London and Honorary Consultant Physician at Barts Health NHS Trust. She is out-going Academic EDI Lead in the Faculty of Medicine at QMUL and former Athena Swan Chair. Chloe holds and has held both national and international leadership roles such as Past President of the Medical Women’s Federation, Past Chair of the British HIV Association and Governing Council of the International AIDS Society.